How do medical aid schemes in South Africa manage chronic medication coverage and what limits apply?
Living with a chronic condition often means managing more than the condition itself. There are specialist consultations to schedule, repeat prescriptions to collect, monitoring tests to complete, and long-term treatment plans to follow. For many people, one of the most important questions is whether their medical scheme will cover the medication they need and, if so, how that cover works.
The answer is more structured than many people realise. Chronic medication benefits are governed by legislation, which means all registered medical schemes in South Africa are required to provide a minimum level of cover for certain chronic conditions. Beyond that, however, schemes may offer additional benefits, broader cover, and enhanced support programmes that can make managing a chronic condition significantly easier.
Understanding how chronic medication benefits work can help members make informed decisions and get the most value from their medical scheme.
The foundation of chronic medication cover in South Africa
Chronic medication cover begins with the Medical Schemes Act and the Prescribed Minimum Benefits (PMBs). PMBs are a set of healthcare benefits that every registered medical scheme must provide, regardless of the benefit option a member chooses. They include emergency medical conditions, approximately 271 diagnosis and treatment pairs, and the Chronic Disease List (CDL), which includes 26 chronic conditions that all schemes must cover.
The Chronic Disease List includes conditions like:
- Asthma
- Diabetes Type 1 and Type 2
- Epilepsy
- Hypertension
- Hypothyroidism
- Bipolar Mood Disorder
- Coronary artery disease
- Chronic obstructive pulmonary disease (COPD)
- Glaucoma
- Chronic renal disease
For these conditions, medical schemes are required to fund the diagnosis, treatment, ongoing management, and approved medication when members meet the relevant clinical criteria and follow the scheme’s registration processes.
Why authorisation is required
One of the most common misunderstandings about chronic medication cover is the belief that a chronic diagnosis automatically qualifies for benefits.
In practice, medical schemes require members to register their condition and obtain authorisation before chronic medication benefits apply. Clinical information supplied by the treating doctor is assessed against established treatment guidelines and protocols.
This process serves several purposes. It ensures that the condition meets the legislated requirements, confirms that treatment aligns with evidence-based clinical guidelines, and allows the scheme to manage benefits consistently across its membership base.
Once approved, members can access medication through the scheme’s chronic medication benefit rather than funding it through day-to-day benefits.
Understanding formularies and medicine lists
Another area that often causes confusion is the difference between a chronic condition and the medication funded for that condition.
Medical schemes generally use formularies, which are approved medicine lists linked to specific chronic conditions. The legislation allows schemes to use these formularies provided they offer treatment that is clinically appropriate and consistent with PMB requirements.
This means a member may be diagnosed with a PMB condition, but only certain medicines for that condition may qualify for funding from the chronic benefit.
Profmed follows this approach through its Chronic Medicine List (CML). Members who qualify for chronic medication benefits receive cover for approved medicines that meet the Scheme’s clinical criteria and formulary requirements. Medication that falls outside these requirements may, depending on the circumstances and benefit option, be funded from other available benefits.
What limits can apply?
Many people are surprised to learn that chronic medication cover is not always unlimited. While PMB legislation requires schemes to fund treatment for approved PMB conditions, schemes are permitted to apply certain benefit management tools. These may include:
- Registration and authorisation requirements
- Clinical treatment protocols
- Approved medicine formularies
- Designated service provider arrangements
- Reference pricing for medicines
- Ongoing clinical reviews and renewals of authorisation
These measures are designed to ensure treatment remains clinically appropriate, cost effective, and sustainable for all members.
Members may also encounter co-payments if they choose medicines outside the approved formulary when equivalent alternatives are available.
For this reason, it is always worth discussing treatment options with both your doctor and your medical scheme before changing medication.
Beyond the legal minimum
While every medical scheme must provide PMB cover, schemes can choose to offer additional chronic medication benefits beyond what legislation requires.
This is often where the differences between schemes become most apparent. Some schemes extend cover to additional chronic conditions beyond the legislated list. Others provide broader medicine formularies, enhanced disease management programmes, or additional support services that help members manage their health more effectively over the long term.
For professionals and their families, these additional benefits can be particularly valuable. Chronic conditions often require ongoing coordination between specialists, pharmacies, and healthcare providers. A scheme that provides comprehensive support can help simplify what may otherwise become a complex healthcare journey.
How Profmed approaches chronic care
As South Africa’s largest restricted medical scheme for professionals, Profmed is designed around the healthcare needs of professional individuals and their families.
Profmed’s chronic medication benefit covers the legislated Chronic Disease List conditions, subject to clinical criteria and medicine formularies. The Scheme’s Chronic Medicine Management Programme supports members through the authorisation process and helps ensure access to appropriate, evidence-based treatment.
Importantly, Profmed’s focus extends beyond simply funding medication. The Scheme recognises that effective chronic disease management is about maintaining long-term health, preventing complications, and helping members continue living and working at their best. This approach aligns with the needs of professionals who value continuity of care, access to quality healthcare, and support that evolves alongside their changing health needs.
The bottom line
Chronic medication cover in South Africa is built on a strong legislative foundation. Every registered medical scheme must provide cover for approved PMB chronic conditions, but access to those benefits depends on registration, authorisation, and compliance with clinical guidelines.
When evaluating a medical scheme, it is worth looking beyond the minimum legal requirements. The breadth of chronic medication benefits, the quality of disease management support, and the overall member experience can make a meaningful difference over the course of a lifelong health journey.
For people managing chronic conditions, comprehensive support is about more than prescriptions. It is about having a healthcare partner that helps make long-term wellness achievable.
Find out more about Profmed’s benefits: https://profmed.co.za/join-profmed/





